Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyrogen Follow-up in Thyroid Cancer
NCT00295763Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2006
- Primary completion
- Jul 2006
- Modality
- Biologic, rProtein (Recombinant Protein), Hormone
- Countries
- 5
01
Overview
A Phase 3 trial of thyrotropin alfa in differentiated thyroid cancer (DTC), sponsored by Sanofi. Started May 2006; status: completed.
02
Drugs
thyrotropin alfa
03
Conditions
differentiated thyroid cancer (DTC)
Beyond the preview
Go deeper on NCT00295763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295763.